Company / Operating Income
Vera Therapeutics, Inc. Operating Income History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$315.5M
FY2025
5-year range
-$315.5M / -$34.4M
FY2021-FY2025
Trend
-88.7%
vs FY2024
Sector context
#167 of 204
Health Care
What the data says
Vera Therapeutics, Inc.'s operating income of -$315M is lower than 82% of companies in the Health Care sector (FY2025). Operating Income has declined for 4 consecutive years, from -$34M in FY2021 to -$315M in FY2025.
Based on SEC 10-K filings.
-$315M in FY2025.
Declined from -$102M to -$315M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 18% in Health CareTop 82% of 204This company -$315.5M Sector average $107.7M
▼
-392.9% below sector average
Key checks
Key Insights
- Vera Therapeutics, Inc.'s operating income has declined for 4 consecutive years.
- In FY2025, operating income decreased 88.7% year-over-year.
- Ranks #167 out of 204 companies in the Health Care sector.
- Peak operating income was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$315.5M | -88.7% |
| FY2024 | -$167.2M | -63.9% |
| FY2023 | -$102.0M | -12.2% |
| FY2022 | -$90.9M | -164.2% |
| FY2021 | -$34.4M | +34.1% |
| FY2020 | -$52.2M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026